CagriSema is a combination therapy of cagrilintide and semaglutide, designed for the treatment of type 2 diabetes and obesity. It is administered as a once-weekly injection and has shown significant results in clinical trials.
CagriSema works by reducing hunger and increasing feelings of fullness, making it effective for weight management
All kits come fully supplied
